Silexion Therapeutics Corp [NASDAQ: SLXN] stock went on an upward path that rose over 1.82% on Wednesday, amounting to a one-week price decrease of less than -4.14%.
Over the last 12 months, SLXN stock dropped by -99.06%. The one-year Silexion Therapeutics Corp stock forecast points to a potential upside of 81.6. The average equity rating for SLXN stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $8.00 million, with 8.69 million shares outstanding and 7.91 million shares in the current float. Compared to the average trading volume of 4.44M shares, SLXN stock reached a trading volume of 5206238 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Silexion Therapeutics Corp [SLXN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SLXN shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SLXN stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Silexion Therapeutics Corp is set at 0.09 The Price to Book ratio for the last quarter was 3.09, with the Price to Cash per share for the same quarter was set at 0.71.
SLXN Stock Performance Analysis:
Silexion Therapeutics Corp [SLXN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.14. With this latest performance, SLXN shares gained by 30.97% in over the last four-week period, additionally sinking by -51.85% over the last 6 months – not to mention a drop of -99.06% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SLXN stock in for the last two-week period is set at 46.37, with the RSI for the last a single of trading hit 44.37, and the three-weeks RSI is set at 46.25 for Silexion Therapeutics Corp [SLXN]. The present Moving Average for the last 50 days of trading for this stock 0.9880, while it was recorded at 0.9278 for the last single week of trading.
Insight into Silexion Therapeutics Corp Fundamentals:
Silexion Therapeutics Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.22 and a Current Ratio set at 3.22.
SLXN Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SLXN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Silexion Therapeutics Corp go to 63.05%.
